Class III Recall

SUN PHARMACEUTICAL INDUSTRIES INC

Product
Clindamycin Phosphate USP, 1% (10 mg/mL), Topical Solution, 60 mL per applicator bottle, Rx only, Mfd. by: Taro Pharmaceutical Industries Ltd., Haifa Bay, Israel; Dist. by: Taro Pharmaceuticals USA, Inc., Hawthorne, NY 10532, NDC# 51672-4081-4
Reason
Failed Impurities/Degradation: Out of Specification results for Total Impurities and for Assay.
Classification
Class III
Status
Ongoing
Lot
Lot#: AD30154, AD31143, AD31145, Exp 11/30/2025
Date
Disclaimer: This tool indexes published US FDA drug-enforcement recall records from all countries, limited to the latest five years. A company or product not appearing here is not proof that it is compliant, approved, safe, or free of FDA action.
SUN PHARMACEUTICAL INDUSTRIES INC — Class III Recall | MedicineWatch US